Veradigm Net Profit Margin 2010-2022 | MDRX
Veradigm net profit margin from 2010 to 2022. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Veradigm Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2022-12-31 | $0.59B | $-0.09B | -14.60% |
| 2022-09-30 | $0.60B | $0.07B | 10.93% |
| 2022-06-30 | $0.60B | $0.07B | 11.22% |
| 2022-03-31 | $0.59B | $0.15B | 26.06% |
| 2021-12-31 | $0.58B | $0.14B | 24.05% |
| 2021-09-30 | $-0.14B | $0.77B | -550.00% |
| 2021-06-30 | $0.08B | $0.76B | 932.10% |
| 2021-03-31 | $0.31B | $0.73B | 234.63% |
| 2020-12-31 | $0.56B | $0.70B | 125.18% |
| 2020-09-30 | $1.43B | $-0.05B | -3.22% |
| 2020-06-30 | $1.51B | $-0.05B | -3.52% |
| 2020-03-31 | $1.58B | $-0.20B | -12.33% |
| 2019-12-31 | $1.63B | $-0.18B | -11.21% |
| 2019-09-30 | $1.63B | $0.21B | 12.94% |
| 2019-06-30 | $1.62B | $0.18B | 11.19% |
| 2019-03-31 | $1.62B | $0.40B | 24.52% |
| 2018-12-31 | $1.62B | $0.36B | 22.51% |
| 2018-09-30 | $1.52B | $0.00B | -0.33% |
| 2018-06-30 | $1.53B | $0.00B | 0.13% |
| 2018-03-31 | $1.52B | $-0.22B | -14.30% |
| 2017-12-31 | $1.50B | $-0.20B | -13.16% |
| 2017-09-30 | $1.55B | $-0.21B | -13.55% |
| 2017-06-30 | $1.49B | $-0.19B | -12.79% |
| 2017-03-31 | $1.45B | $-0.05B | -3.23% |
| 2016-12-31 | $1.39B | $-0.03B | -1.80% |
| 2016-09-30 | $1.47B | $0.00B | -0.14% |
| 2016-06-30 | $1.43B | $0.00B | 0.21% |
| 2016-03-31 | $1.40B | $0.01B | 0.72% |
| 2015-12-31 | $1.39B | $0.00B | -0.14% |
| 2015-09-30 | $1.38B | $-0.02B | -1.45% |
| 2015-06-30 | $1.37B | $-0.04B | -2.99% |
| 2015-03-31 | $1.37B | $-0.06B | -4.08% |
| 2014-12-31 | $1.38B | $-0.07B | -4.87% |
| 2014-09-30 | $1.39B | $-0.09B | -6.20% |
| 2014-06-30 | $1.37B | $-0.11B | -7.94% |
| 2014-03-31 | $1.37B | $-0.11B | -8.35% |
| 2013-12-31 | $1.37B | $-0.11B | -7.65% |
| 2013-09-30 | $1.37B | $-0.11B | -7.87% |
| 2013-06-30 | $1.40B | $-0.05B | -3.56% |
| 2013-03-31 | $1.43B | $-0.02B | -1.33% |
| 2012-12-31 | $1.45B | $0.00B | -0.07% |
| 2012-09-30 | $1.48B | $0.05B | 3.30% |
| 2012-06-30 | $1.49B | $0.06B | 3.97% |
| 2012-03-31 | $1.47B | $0.07B | 4.55% |
| 2011-12-31 | $1.44B | $0.07B | 5.12% |
| 2011-09-30 | $1.37B | $0.04B | 3.06% |
| 2011-06-30 | $1.25B | $0.02B | 1.92% |
| 2011-03-31 | $1.08B | $0.02B | 1.94% |
| 2010-09-30 | $0.62B | $0.03B | 5.35% |
| 2010-06-30 | $0.56B | $0.05B | 9.01% |
| 2010-03-31 | $0.53B | $0.05B | 9.94% |
| 2010-02-28 | $0.51B | $0.05B | 9.14% |
| 2009-09-30 | $0.49B | $0.04B | 7.94% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.487B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.950B | 58.46 |
| Tempus AI (TEM) | United States | $11.831B | 0.00 |
| Doximity (DOCS) | United States | $11.347B | 52.53 |
| Hims & Hers Health (HIMS) | United States | $10.359B | 107.63 |
| IRhythm Technologies (IRTC) | United States | $4.875B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.826B | 59.77 |
| Hinge Health (HNGE) | United States | $3.508B | 0.00 |
| Privia Health (PRVA) | United States | $2.682B | 183.33 |
| Enovis (ENOV) | United States | $1.843B | 10.27 |
| Phreesia (PHR) | United States | $1.663B | 0.00 |
| Schrodinger (SDGR) | United States | $1.503B | 0.00 |
| 10x Genomics (TXG) | United States | $1.441B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.420B | 0.00 |
| Azenta (AZTA) | United States | $1.409B | 65.47 |
| Omnicell (OMCL) | United States | $1.351B | 23.83 |
| Evolent Health (EVH) | United States | $1.262B | 107.50 |
| Claritev (CTEV) | United States | $0.703B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.597B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.500B | 0.00 |
| Standard BioTools (LAB) | United States | $0.482B | 0.00 |
| Talkspace (TALK) | United States | $0.460B | 137.50 |
| Outset Medical (OM) | United States | $0.357B | 0.00 |
| TruBridge (TBRG) | United States | $0.355B | 787.33 |
| Nyxoah SA (NYXH) | Belgium | $0.262B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.261B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.207B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.165B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.133B | 0.00 |
| American Well (AMWL) | United States | $0.118B | 0.00 |
| Pulmonx (LUNG) | United States | $0.104B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.096B | 3.68 |
| 111 (YI) | China | $0.064B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.051B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.031B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |